Shmuel Tuvia
Chief Tech/Sci/R&D Officer presso AYALA PHARMACEUTICALS, INC.
Profilo
Shmuel Tuvia was the founder of Eloxx Pharmaceuticals Ltd.
founded in 2013, where he held the position of Chief Operating Officer & Director from 2013 to 2017.
Currently, he is the Chief Scientific Officer at Ayala Pharmaceuticals, Inc. since 2022.
Dr. Tuvia's former positions include Chief Development Officer at Ukko Inc. from 2020 to 2022 and Vice President-Preclinical Research at Amryt Pharma Plc from 2009 to 2013.
Dr. Tuvia's education includes undergraduate and graduate degrees from Tel-Aviv University and a doctorate from Sackler School of Medicine.
Posizioni attive di Shmuel Tuvia
| Società | Posizione | Inizio |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Precedenti posizioni note di Shmuel Tuvia
| Società | Posizione | Fine |
|---|---|---|
Ukko Inc.
 Ukko Inc. Miscellaneous Commercial ServicesCommercial Services Ukko Inc. operates as a stealth biotech company. It provides solutions to food allergies and disorders. The company was founded by Anat Binur and Yanay Ofran in 2016 and is headquartered in Mountain View, CA. | Corporate Officer/Principal | 01/05/2022 |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Founder | 01/07/2017 |
| AMRYT PHARMA PLC | Corporate Officer/Principal | 01/11/2013 |
Formazione di Shmuel Tuvia
| Tel-Aviv University | Graduate Degree |
| Sackler School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Aziende private | 3 |
|---|---|
Eloxx Pharmaceuticals Ltd.
Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Health Technology |
Ukko Inc.
Ukko Inc. Miscellaneous Commercial ServicesCommercial Services Ukko Inc. operates as a stealth biotech company. It provides solutions to food allergies and disorders. The company was founded by Anat Binur and Yanay Ofran in 2016 and is headquartered in Mountain View, CA. | Commercial Services |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Shmuel Tuvia
